These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32038614)

  • 21. Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine.
    Jeon JH; Lee HJ; Jang GY; Kim CW; Shim DM; Cho SY; Yeo EJ; Park SC; Kim IG
    Exp Mol Med; 2004 Dec; 36(6):576-81. PubMed ID: 15675041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revisiting hypoxia therapies for tuberculosis.
    Oehlers SH
    Clin Sci (Lond); 2019 Jun; 133(12):1271-1280. PubMed ID: 31209098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis.
    Guler R; Ozturk M; Sabeel S; Motaung B; Parihar SP; Thienemann F; Brombacher F
    Front Immunol; 2021; 12():733853. PubMed ID: 34745105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berbamine promotes macrophage autophagy to clear
    Zhang S; Zhou X; Ou M; Fu X; Lin Q; Tao X; Wang Z; Liu A; Li G; Xu Y; Zhang G
    mBio; 2023 Aug; 14(4):e0027223. PubMed ID: 37382506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis.
    Jang JH; Park JS; Lee TJ; Kwon TK
    Cancer Lett; 2010 Jan; 287(2):224-30. PubMed ID: 19632032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future.
    Rao M; Ippolito G; Mfinanga S; Ntoumi F; Yeboah-Manu D; Vilaplana C; Zumla A; Maeurer M
    Int J Infect Dis; 2019 Mar; 80S():S62-S67. PubMed ID: 30685590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loperamide Restricts Intracellular Growth of Mycobacterium tuberculosis in Lung Macrophages.
    Juárez E; Carranza C; Sánchez G; González M; Chávez J; Sarabia C; Torres M; Sada E
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):837-847. PubMed ID: 27468130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of tissue transglutaminase in age-associated ventricular stiffness.
    Oh YJ; Pau VC; Steppan J; Sikka G; Bead VR; Nyhan D; Levine BD; Berkowitz DE; Santhanam L
    Amino Acids; 2017 Mar; 49(3):695-704. PubMed ID: 27438265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)--a novel, patentable approach to limit the emergence of XDR-TB.
    Martins M
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):110-7. PubMed ID: 21517742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
    Abreu R; Giri P; Quinn F
    Front Immunol; 2020; 11():1553. PubMed ID: 32849525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility.
    Raffetseder J; Pienaar E; Blomgran R; Eklund D; Patcha Brodin V; Andersson H; Welin A; Lerm M
    PLoS One; 2014; 9(11):e112426. PubMed ID: 25386849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein Kinase R Restricts the Intracellular Survival of
    Smyth R; Berton S; Rajabalee N; Chan T; Sun J
    Front Microbiol; 2020; 11():613963. PubMed ID: 33552025
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Woo M; Wood C; Kwon D; Park KP; Fejer G; Delorme V
    Front Immunol; 2018; 9():438. PubMed ID: 29593716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant methylation of host macrophages induced by tuberculosis infection.
    Behrouzi A; Hadifar S; Amanzadeh A; Riazi Rad F; Vaziri F; Siadat SD
    World J Microbiol Biotechnol; 2019 Oct; 35(11):168. PubMed ID: 31654206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
    Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
    J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy.
    Liu Y; Wang J; Yang J; Xia J; Yu J; Chen D; Huang Y; Yang F; Ruan Y; Xu JF; Pi J
    J Nanobiotechnology; 2024 Oct; 22(1):608. PubMed ID: 39379986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Macrophage Response to
    Maphasa RE; Meyer M; Dube A
    Front Cell Infect Microbiol; 2020; 10():618414. PubMed ID: 33628745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NFκB and Autophagy Dependent Bacillary Killing.
    Lawlor C; O'Connor G; O'Leary S; Gallagher PJ; Cryan SA; Keane J; O'Sullivan MP
    PLoS One; 2016; 11(2):e0149167. PubMed ID: 26894562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.